SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-23-163091
Filing Date
2023-06-08
Accepted
2023-06-08 09:16:24
Documents
4
Group Members
SNBL23 MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d489013dsctota.htm SC TO-T/A 23408
2 EX-99.(A)(5)(IV) d489013dex99a5iv.htm EX-99.(A)(5)(IV) 66561
3 EX-99.(D)(9) d489013dex99d9.htm EX-99.(D)(9) 131889
4 GRAPHIC g489013g0608080937745.jpg GRAPHIC 1751
  Complete submission text file 0001193125-23-163091.txt   226724
Mailing Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394
Business Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394 81-99-294-2600
Shin Nippon Biomedical Laboratories, Ltd. (Filed by) CIK: 0001657770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 1231
Type: SC TO-T/A

Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-91126 | Film No.: 231000836
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-91126 | Film No.: 231000835
SIC: 2834 Pharmaceutical Preparations